![]() | |
| Clinical data | |
|---|---|
| Other names | Metynodiol diacetate; SC-19198; 11β-Methyletynodiol diacetate; 11β-Methyl-19-norpregn-4-en-20-yne-3β,17α-diyl diacetate; 11β-Methyl-17α-ethynylestr-4-ene-3β,17β-diol diacetate |
| Drug class | Progestogen; Progestogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C25H34O4 |
| Molar mass | 398.543 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Methynodiol diacetate (USAN) (developmental code name SC-19198), or metynodiol diacetate, also known as 11β-methyletynodiol diacetate, is a steroidal progestin of the 19-nortestosterone group which was patented in 1968 but was never marketed.[1] It is the diacetate ester of metynodiol, which, similarly, was never marketed.[1]
See also
References
- 1 2 Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 820–. ISBN 978-1-4757-2085-3.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
